iSpecimen (ISPC) Stock Analysis: AI Score & Alternative Data
Alt-data signals are cooling for iSpecimen
Is iSpecimen a buy right now? The alternative data leans no. This ISPC stock analysis is built on the 25+ alternative data signals AltIndex tracks on iSpecimen every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 38/100: a Sell. The stock trades at $1.55 with a $4M market cap.
The 90-day pressure points: web traffic down 27.0% to 6K monthly visits, headcount (according to LinkedIn) down 19.0% to 17 employees, and just 37% of employees report a positive business outlook. Stocks scoring below 40 have historically lagged the market.
ISPC’s broader alt-data profile also covers Facebook followers (229), Reddit mentions (1 a day), and sentiment (98/100). Every signal links to its own page with full history, the ISPC technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on ISPC is just below.
iSpecimen AI Stock Analysis
iSpecimen is a company operating in the healthcare and research sector, providing a unique platform for obtaining human biospecimens, including blood, tissue, urine, and other biological materials, to support scientific research and clinical trials.
Analysis generated September 2, 2026.
Recent iSpecimen Stock Alerts
|
iSpecimen | September 9 Price is down by -6.3% in the last 24h. |
|
iSpecimen | September 8 Price is up by 20.8% in the last 24h. |
|
iSpecimen | August 24 Price is down by -8.9% in the last 24h. |
|
iSpecimen | August 21 Price is down by -17.4% in the last 24h. |
iSpecimen Alternative Data
| Alternative Data | Value | 3m Change | Trend |
|---|---|---|---|
| Webpage Traffic | 6K | 27.0% | |
| Job Posts | 0 | N/A | |
| LinkedIn Employees | 17 | 19.0% | |
| Employee Recommend | 51 | 0% | |
| Business Outlook | 37 | 0% | |
| Sentiment | 98 | 2.0% | |
| Reddit Mentions | 1 | N/A | |
| X Mentions | 2 | N/A | |
| Stocktwits Mentions | 223 | 555.9% | |
| News Mentions | 1 | N/A | |
| Stocktwits Subscribers | 9K | 0% | |
| Facebook Followers | 229 | 1.8% | |
| Facebook Engagement | 0 | N/A |
About iSpecimen (ISPC)
iSpecimen, Inc. provides technology that connects life science researchers in need of human biofluids, tissues and living cells for their research with biospecimens available from healthcare provider organizations globally. The company is headquartered in Lexington, Massachusetts.
| Price | $1.55 |
| Target Price | $387.74 |
| Volume | 63,420,177 |
| Market Cap | $4M |
| Year Range | $1 – $78 |
| Dividend Yield | 0% |
| PE Ratio | — |
| Analyst Rating | 38% buy |
| Industry | Health Care Services |
Latest iSpecimen News
View more → |
Why iSpecimen Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving PremarketSeptember 8 - Biztoc.com |
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded WarrantsAugust 7 - GlobeNewswire |
|
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimenAugust 7 - GlobeNewswire |
|
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private PlacementMay 12 - GlobeNewswire |
|
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private PlacementMay 8 - GlobeNewswire |
|
See iSpecimen’s complete price and AI Score history
Sign up to unlock 1-year and all-time charts for ISPC, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREEiSpecimen Earnings & Financial Performance
View all earnings →iSpecimen Insider Trading Activity
View all →| No recent insider transactions on file. |
iSpecimen Congress Trading
View all →| Politician | Filing Date | Type | Size |
|---|---|---|---|
| No congress trades on file. | |||
Stocks Similar to iSpecimen
See all →| Company | Price | Market Cap | AI Score | |
|---|---|---|---|---|
 |
Inspire Veterinary PartnersIVP |
$0.03 16.1% | $4M | 48 |
 |
NewGenIvf GroupNIVF |
$1.10 0.9% | $2M | 48 |
 |
Hong Kong Pharma DigitalHKPD |
$0.13 0.3% | $6M | 48 |
 |
XWELLXWEL |
$0.93 2.8% | $8M | 46 |
 |
Check-CapMBAI |
$6.42 0.9% | $9M | 46 |
Explore iSpecimen Data
Frequently Asked Questions: iSpecimen (ISPC)
iSpecimen has an AltIndex AI Score of 38/100 (Sell). The score reflects negative alternative data signals. All investments carry risk.
38/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.
Currently, the price of one share of iSpecimen (ISPC) stock is $1.55 with a market cap of $4M.
As of today, iSpecimen’s PE (Price to Earnings) ratio is —.
View the latest iSpecimen insider transactions to see recent buying and selling activity by company executives and directors.
Check the iSpecimen congress trading page for the latest disclosed trades by U.S. senators and representatives.
AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.
The ISPC stock price chart above shows iSpecimen’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full iSpecimen technical analysis for RSI, moving averages, and more.
See the stocks similar to iSpecimen section on this page for companies in the same industry ranked by market cap and AI Score.
